YolTech Therapeutics, a clinical-stage biotechnology company developing next-generation in vivo gene editing therapies, today announced that the U.S. Food and Drug Administration (FDA) has cleared the ...

The breakthrough marks the country’s entry into advanced gene-editing therapeutics, an area so far dominated by a handful of ...

An experimental gene-editing therapy developed by Crispr Therapeutics is showing promise for treating heart disease.

Setting a new milestone in Atmanirbhar Bharat, the government on Wednesday launched an indigenous CRISPR-based gene therapy ...

Promising results from a small clinical trial highlight a growing interest in designing gene-editing treatments for common ...

In a world-first trial, scientists used a one-off CRISPR gene edit to switch off a liver “fat brake” gene, slashing stubborn ...

Researchers report early but encouraging results on an experimental gene-editing treatment for high cholesterol.

The approach is “very exciting,” but one expert says a lot more research is needed, especially around safety, before clinical ...

In a major step forward for cancer care, researchers at ChristianaCare's Gene Editing Institute have shown that disabling the NRF2 gene with CRISPR technology can reverse chemotherapy resistance in ...

Cone rod dystrophy is a rare inherited retinal disorder impacting cones and rods, leading to progressive vision loss. The market for cone rod dystrophy is poised for growth due to rising disease ...

A Greer couple is hosting a fundraiser to support a costly gene editing procedure for their two children, who suffer from a ...

Researchers in Australia have led a first-in-human trial for a breakthrough gene-editing therapy that halves bad cholesterol ...